174 related articles for article (PubMed ID: 14531350)
1. [FDG-PET and CT in gastrointestinal stromal tumor treated with imatinib].
Eigtved AI; Berthelsen AK; Kinnander C; Krarup-Hansen A
Ugeskr Laeger; 2003 Sep; 165(37):3507-9. PubMed ID: 14531350
[TBL] [Abstract][Full Text] [Related]
2. F-18 FDG PET imaging in gastrointestinal stromal tumor.
Reddy MP; Reddy P; Lilien DL
Clin Nucl Med; 2003 Aug; 28(8):677-9. PubMed ID: 12897659
[TBL] [Abstract][Full Text] [Related]
3. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
Gayed I; Vu T; Iyer R; Johnson M; Macapinlac H; Swanston N; Podoloff D
J Nucl Med; 2004 Jan; 45(1):17-21. PubMed ID: 14734662
[TBL] [Abstract][Full Text] [Related]
4. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
[TBL] [Abstract][Full Text] [Related]
5. Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors.
Antoch G; Kanja J; Bauer S; Kuehl H; Renzing-Koehler K; Schuette J; Bockisch A; Debatin JF; Freudenberg LS
J Nucl Med; 2004 Mar; 45(3):357-65. PubMed ID: 15001674
[TBL] [Abstract][Full Text] [Related]
6. Patterns of extension of gastrointestinal stromal tumors (GIST) treated with imatinib (Gleevec®) by 18F-FDG PET/CT.
Valls-Ferrusola E; García-Garzón JR; Ponce-López A; Soler-Peter M; Fuertes-Cabero S; Moragas-Solanes M; Riera-Gil E; Carrió-Gasset I; Lomeña-Caballero F
Rev Esp Enferm Dig; 2012 Jul; 104(7):360-6. PubMed ID: 22849497
[TBL] [Abstract][Full Text] [Related]
7. Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PET.
Jager PL; Gietema JA; van der Graaf WT
Nucl Med Commun; 2004 May; 25(5):433-8. PubMed ID: 15100500
[TBL] [Abstract][Full Text] [Related]
8. 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec).
Stroobants S; Goeminne J; Seegers M; Dimitrijevic S; Dupont P; Nuyts J; Martens M; van den Borne B; Cole P; Sciot R; Dumez H; Silberman S; Mortelmans L; van Oosterom A
Eur J Cancer; 2003 Sep; 39(14):2012-20. PubMed ID: 12957455
[TBL] [Abstract][Full Text] [Related]
9. Highlighting the role of FDG PET scan in early response assessment of gastrointestinal stromal tumor treated with imatinib mesylate.
Abhyankar SA; Nair N
Clin Nucl Med; 2008 Mar; 33(3):213-4. PubMed ID: 18287851
[No Abstract] [Full Text] [Related]
10. Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs).
Van den Abbeele AD; Badawi RD
Eur J Cancer; 2002 Sep; 38 Suppl 5():S60-5. PubMed ID: 12528774
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study.
Goldstein D; Tan BS; Rossleigh M; Haindl W; Walker B; Dixon J
Oncology; 2005; 69(4):326-32. PubMed ID: 16293972
[TBL] [Abstract][Full Text] [Related]
12. CT evaluation of gastrointestinal stromal tumors treated with imatinib mesylate.
Erturk SM
AJR Am J Roentgenol; 2005 Nov; 185(5):1366; author reply 1366-7. PubMed ID: 16247167
[No Abstract] [Full Text] [Related]
13. An FDG positron emission tomographic study in a case of gastrointestinal stromal tumor.
Chander S; Lay Ergun E; Shields AF
Clin Nucl Med; 2003 Apr; 28(4):327-9. PubMed ID: 12642718
[No Abstract] [Full Text] [Related]
14. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.
Choi H; Charnsangavej C; Faria SC; Macapinlac HA; Burgess MA; Patel SR; Chen LL; Podoloff DA; Benjamin RS
J Clin Oncol; 2007 May; 25(13):1753-9. PubMed ID: 17470865
[TBL] [Abstract][Full Text] [Related]
15. The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate.
Goerres GW; Stupp R; Barghouth G; Hany TF; Pestalozzi B; Dizendorf E; Schnyder P; Luthi F; von Schulthess GK; Leyvraz S
Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):153-62. PubMed ID: 15690223
[TBL] [Abstract][Full Text] [Related]
16. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings.
Choi H; Charnsangavej C; de Castro Faria S; Tamm EP; Benjamin RS; Johnson MM; Macapinlac HA; Podoloff DA
AJR Am J Roentgenol; 2004 Dec; 183(6):1619-28. PubMed ID: 15547201
[TBL] [Abstract][Full Text] [Related]
17. [Utility of FDG-PET for early evaluation of efficiency of imatinib mesylate (Glivec) in the treatment of gastrointestinal stromal tumors].
García-González J; Sánchez Salmón A; Areses Manrique C; León Mateos L; Barandela Salgado J; López López R
Rev Esp Med Nucl; 2007; 26(2):100-2. PubMed ID: 17386236
[TBL] [Abstract][Full Text] [Related]
18. Early detection of response to imatinib therapy for gastrointestinal stromal tumor by using 18F-FDG-positron emission tomography and computed tomography imaging.
Zincirkeser S; Sevinc A; Kalender ME; Camci C
World J Gastroenterol; 2007 Apr; 13(15):2261-2. PubMed ID: 17465516
[TBL] [Abstract][Full Text] [Related]
19. Downstaging of an advanced gastrointestinal stromal tumor by neoadjuvant imatinib.
de Vos tot Nederveen Cappel RJ; van Hillegersberg R; Rodenhuis S; Peterse JL; van Coevorden F
Dig Surg; 2004; 21(1):77-9. PubMed ID: 14967958
[No Abstract] [Full Text] [Related]
20. 18F-Fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic review.
Treglia G; Mirk P; Stefanelli A; Rufini V; Giordano A; Bonomo L
Clin Imaging; 2012; 36(3):167-75. PubMed ID: 22542374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
